Bill Neubach
Senior Medical Science Liaison- West @UroGen Pharma
Signup · Get unlimited contacts
WORK HISTORY
Senior Medical Science Liaison- West @UroGen Pharma
San Diego, US
Responsibilities include clinical dissemination of product information, on label and off label, in the area of community and academic focus in the West for UGN-101 and 102 in UTUC, NMIBC,as well as pipeline responsibilities to include a novel oncolytic virus delivery, all centered in RTGeL technology. This area of oncology specific to GU Oncology and potentially other areas as pipeline grows.
EDUCATION
Johns Hopkins Bloomberg School of Public Health
Certificate with Honors, Cancer Cell Biology
SITC
Certificate, Immunology and Cancer Therapy.
Johns Hopkins Bloomberg School of Public Health
Certificate- Completed, Design and Interpretation of Clinical Trials
Wake Forest University
BSc.-Physiology, Minor-Biology
Yale University
Certificate, Essentials Of Global Health
Johns Hopkins Bloomberg School of Public Health
Certificate, Cancer Biology and Metastasis
Johns Hopkins Bloomberg School of Public Health
Certificate Course ( Completed June 6th, 2019), Advanced Genomics and Genetic Data Science
Vanderbilt University School of Medicine
Certificate Completed, Case Studies in Personalized Medicine
ABOUT BILL NEUBACH
With extensive expertise in oncology and biotechnology, I bring over 20 years of diverse experience in the pharmaceutical and life sciences industries. Currently serving as a Senior Medical Science Liaison at UroGen Pharma, my work centers on disseminating clinical information on UGN-101 and UGN-102 for UTUC and NMIBC, alongside contributing to the development of innovative therapeutics, including a novel oncolytic virus and RTGel technology. My role emphasizes oncology, particularly GU oncology, and includes pipeline expansion efforts. My professional journey reflects a strong commitment to advancing oncology research and patient outcomes. I have developed expertise in managed care, biotechnology, and strategic commercialization within oncology and rare disease spaces. My focus has been on fostering cross-functional collaboration, engaging thought leaders, and supporting clinical strategy. I strive to bring impactful therapies to market, contributing to the progress of cancer treatment while emphasizing innovation and patient-centered care.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.